D. E. Shaw & Co., Inc. - AVEO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$20,000
-47.4%
31,275
-44.4%
0.00%
Q2 2019$38,000
-78.8%
56,200
-74.3%
0.00%
Q1 2019$179,000
-60.7%
218,789
-23.1%
0.00%
-100.0%
Q4 2018$455,000
+810.0%
284,645
+717.8%
0.00%
Q1 2015$50,000
-93.0%
34,805
-95.9%
0.00%
-100.0%
Q4 2014$711,000
-22.7%
845,751
+2.0%
0.00%0.0%
Q3 2014$920,000
-51.2%
829,210
-19.5%
0.00%
-66.7%
Q2 2014$1,886,000
+14.0%
1,030,292
-6.9%
0.00%
+50.0%
Q1 2014$1,655,000
-2.8%
1,106,682
+19.6%
0.00%0.0%
Q4 2013$1,702,000
+1.1%
925,254
+13.7%
0.00%
-33.3%
Q3 2013$1,684,000
+69.2%
813,645
+104.4%
0.00%
+50.0%
Q2 2013$995,000398,0470.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Greylock XI GP Limited Partnership 584,004$1,068,000100.00%
GREAT POINT PARTNERS LLC 2,325,000$4,255,0001.89%
Sarissa Capital Management LP 2,570,759$4,704,0001.60%
Deer VI & Co. LLC 675,242$1,236,0000.68%
Palo Alto Investors LP 1,200,800$2,197,0000.16%
Baupost Group 3,829,350$7,008,0000.11%
Gruss Capital Management LP 533,253$976,0000.05%
Granahan Investment Management 676,451$1,238,0000.04%
Fore Research & Management, LP 674,200$1,233,0000.04%
TFS CAPITAL LLC 210,369$385,0000.03%
View complete list of AVEO PHARMACEUTICALS INC shareholders